The most dangerous animal in the world just got easier to study-and perhaps defeat one day.
SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot ...
The most dangerous animal in the world just got easier to study—and perhaps defeat one day. Researchers from Rockefeller ...
A research team led by the Institute for Bioengineering of Catalonia (IBEC) and collaborating with the Biomedical Research ...
By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...
An experimental compound reduced the cell death, inflammation, and organ damage seen with diabetes.
SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), announced that Nanoviricides CEO Dr Anil Diwan joined ...
There are a number of considerations that can help streamline the pathway to the clinic. One of the first is which vector system will be used, with AAV and lentivirus being two of the most commonly ...
A research team led by the Institute for Bioengineering of Catalonia (IBEC) and collaborating with the Biomedical Research Institute of A Coruña ...